the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
March 15, 2020 – An international study published in the journal Cell has described 109 genetic variants associated with eight psychiatric disorders such as autism, ADHD, schizophrenia, bipolar disorder, depression, obsessive-compulsive disorder and Tourette syndrome in a total of about 230,000 …
Large genetic map of psychiatric disorders completed Read more »
May 11, 2016 – We do learn from a very recent Drug Safety Communication (DSC) by the American Food & Drug Administration (FDA) that olanzapine, the pharmacologically active component in Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, Symbyax, and olanzapine generics may cause …
DRESS: Rare but serious skin reaction with Zyprexa (Olanzapine) Read more »
February 04, 2016 – Genetic variations on a stretch of chromosome may predict responsiveness among patients with bipolar disorder to the mood stabilizing drug lithium (multiple brands), a genome-wide analysis by an international consortium shows. Lithium is a first-line treatment for …
Genetic Variants Predict Lithium Response in Bipolar Disorder Read more »